Cargando…
Indeterminacy of cannabis impairment and ∆(9)-tetrahydrocannabinol (∆(9)-THC) levels in blood and breath
Previous investigators have found no clear relationship between specific blood concentrations of ∆(9)-tetrahydrocannabinol (∆(9)-THC) and impairment, and thus no scientific justification for use of legal “per se” ∆(9)-THC blood concentration limits. Analyzing blood from 30 subjects showed ∆(9)-THC c...
Autores principales: | Wurz, Gregory T., DeGregorio, Michael W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117256/ https://www.ncbi.nlm.nih.gov/pubmed/35585089 http://dx.doi.org/10.1038/s41598-022-11481-5 |
Ejemplares similares
-
A comprehensive breath test that confirms recent use of inhaled cannabis within the impairment window
por: DeGregorio, Michael W., et al.
Publicado: (2021) -
Examining impairment and kinetic patterns associated with recent use of hemp-derived Δ(8)-tetrahydrocannabinol: case studies
por: Wurz, Gregory T., et al.
Publicado: (2022) -
Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review
por: Poyatos, Lourdes, et al.
Publicado: (2020) -
Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis
por: Hutten, Nadia R. P. W., et al.
Publicado: (2022) -
Identification of ∆9-tetrahydrocannabinol (THC) impairment using functional brain imaging
por: Gilman, Jodi M., et al.
Publicado: (2022)